A regulatory role for RIP140 in nuclear receptor activation

Molecular Endocrinology

Volumn 12, Issue 6, 1998, Pages 864-881

  Treuter, E ^a   Albrektsen, T ^a   Johansson, L ^a   Leers, J ^a   Gustafsson, J A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; DNA; LIGAND; NUCLEAR FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN P300; THYROID HORMONE RECEPTOR;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; LIGAND BINDING; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0032230248     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.12.6.0123     Document Type: Article

References (78)

1. The RXR heterodimers and orphan receptors
2. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor
3. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
4. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid x receptor heterodimers with ligands, coactivators, and corepressors
5. LXR, a nuclear receptor that defines a distinct retinoid response pathway
6. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists
7. Unique response pathways are established by allosteric interactions among nuclear hormone receptors
8. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding
9. Polarity-specific activities of retinoic acid receptors determined by a co-repressor
10. The PPAR-alpha-leukotriene B-4 pathway to inflammation control
11. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma
12. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta
13. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay
14. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)
15. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation
16. Adipocyte differentiation - A transcriptional regulatory cascade
17. Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology
18. The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing
19. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor
20. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors
21. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: Presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity
22. Nuclear receptor coactivators
23. Nuclear receptor coactivators and corepressors
24. A transcriptional co-repressor that interacts with nuclear hormone receptors
25. Identification of TRACs (T-3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors
26. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor
27. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR
28. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT)
29. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains
30. Stoichiometric and steric principles governing repression by nuclear hormone receptors
31. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen
32. Role of CBP/p300 in nuclear receptor signalling
33. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
34. P300 is a component of an estrogen receptor coactivator complex
35. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
36. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription
37. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
38. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors
39. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator
40. Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine
41. Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor gamma
42. The CBP co-activator is a histone acetyltransferase
43. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
44. Steroid receptor coactivator-1 is a histone acetyltransferase
45. Estrogen receptor-associated proteins: Possible mediators of hormone-induced transcription
46. Interaction of proteins with transcriptionally active estrogen receptors
47. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor
48. RIP140 interacts with multiple nuclear receptors by means of two distinct sites
49. A natural transactivation mutation in the thyroid hormone beta receptor: Impaired interaction with putative transcriptional mediators
50. The transcriptional coactivator p/CIP binds CBP and mediates nuclear-receptor function
51. RIP140 enhances nuclear receptor-dependent transcription in vivo in yeast
52. A novel genetic system to detect protein-protein interactions
53. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells
54. A canonical structure for the ligand-binding domain of nuclear receptors
55. A signature motif in transcriptional co-activators mediates binding to nuclear receptors
56. A possible involvement of TIF1-alpha and TIF1-beta in the epigenetic control of transcription by nuclear receptors
57. Activation and repression by nuclear hormone receptors: Hormone modulates an equilibrium between active and repressive states
58. The phantom ligand effect: Allosteric control of transcription by the retinoid X receptor
59. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor
60. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1
61. Peroxisome proliferator-activated receptor response specificities as defined in yeast and mammalian cell transcription assays
62. Transactivation by PPAR/RXR heterodimers in yeast is potentiated by exogenous fatty acid via a pathway requiring intact peroxisomes
63. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors
64. Coexpression of nuclear receptor partners increases their solubility and biological activities
65. Cloning and identification of rat deoxyuridine triphosphatase as an inhibitor of peroxisome proliferator-activated receptor alpha
66. Steroid receptor induction of gene transcription - A two-step model
67. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
68. The transcriptional coactivators p300 and CBP are histone acetyltransferases
69. Transcription - A growing coactivator network
70. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors
71. Yeast hormone response element assays detect and characterize GRIP1 coactivator-dependent activation of transcription by thyroid and retinoid nuclear receptors
72. Drosophila TAF(II)230 and the transcriptional activator VP16 bind competitively to the TATA box-binding domain of the TATA box-binding protein
73. Activities in Pit-1 determine whether receptor interacting protein 140 activates or inhibits Pit-1 nuclear receptor transcriptional synergy
74. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
75. Novel sequence determinants in peroxisome proliferator signaling
76. Interaction of human thyroid hormone receptor beta with transcription factor TFIIB may mediate target gene derepression and activation by thyrcid hormone
77. Role of acidic and phosphorylated residues in gene activation by the glucocorticoid receptor